United Therapeutics Corporation (UTHR) — Cash Flow-to-Debt Ratio
United Therapeutics Corporation (UTHR) has a Cash Flow-to-Debt Ratio of 0.74x as of September 2025, meaning its operating cash flow of $562.10 Million could theoretically repay 1% of its total liabilities ($760.90 Million) in one year. See UTHR free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
United Therapeutics Corporation Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for United Therapeutics Corporation across 27 annual periods. For the full cash flow conversion analysis, see how efficiently does United Therapeutics Corporation generate cash.
Annual Cash Flow-to-Debt Ratio for United Therapeutics Corporation (1998–2024)
Year-by-year debt coverage analysis for United Therapeutics Corporation. Check cash flow quality index of United Therapeutics Corporation to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | $1.33 Billion | $920.00 Million | ▲ +74.4% |
| 2023 | 0.83x | $978.00 Million | $1.18 Billion | ▲ +28.6% |
| 2022 | 0.64x | $802.50 Million | $1.25 Billion | ▲ +30.1% |
| 2021 | 0.49x | $598.20 Million | $1.21 Billion | ▼ -20.2% |
| 2020 | 0.62x | $755.70 Million | $1.22 Billion | ▲ +439.8% |
| 2019 | -0.18x | $-206.60 Million | $1.13 Billion | ▼ -114.3% |
| 2018 | 1.27x | $778.40 Million | $612.40 Million | ▲ +108.4% |
| 2017 | 0.61x | $474.20 Million | $777.60 Million | ▼ -56.1% |
| 2016 | 1.39x | $643.60 Million | $463.40 Million | ▲ +112.2% |
| 2015 | 0.65x | $382.80 Million | $584.80 Million | ▲ +14.0% |
| 2014 | 0.57x | $355.30 Million | $618.84 Million | ▲ +5.7% |
| 2013 | 0.54x | $425.27 Million | $783.26 Million | ▼ -10.8% |
| 2012 | 0.61x | $323.63 Million | $531.73 Million | ▲ +38.6% |
| 2011 | 0.44x | $250.19 Million | $569.59 Million | ▲ +13.7% |
| 2010 | 0.39x | $211.53 Million | $547.75 Million | ▲ +54.3% |
| 2009 | 0.25x | $99.72 Million | $398.54 Million | ▲ +285.0% |
| 2008 | -0.14x | $-49.20 Million | $363.62 Million | ▼ -180.5% |
| 2007 | 0.17x | $48.95 Million | $291.23 Million | ▼ -6.8% |
| 2006 | 0.18x | $49.39 Million | $273.94 Million | ▼ -93.2% |
| 2005 | 2.65x | $43.17 Million | $16.31 Million | ▲ +97.7% |
| 2004 | 1.34x | $20.78 Million | $15.52 Million | ▲ +283.5% |
| 2003 | -0.73x | $-8.56 Million | $11.74 Million | ▲ +57.7% |
| 2002 | -1.72x | $-22.26 Million | $12.91 Million | ▲ +30.3% |
| 2001 | -2.47x | $-38.90 Million | $15.72 Million | ▼ -26.5% |
| 2000 | -1.96x | $-31.11 Million | $15.91 Million | ▲ +48.0% |
| 1999 | -3.76x | $-23.70 Million | $6.30 Million | ▲ +21.6% |
| 1998 | -4.80x | $-9.60 Million | $2.00 Million | — |